USPTO serial 79363539
DUOSPORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 16, 2024
- Examiner
- BLANE, SUZANNE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DUOSPORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy C. Bradley
Timothy C. Bradley Carlson, Gaskey & Olds, P.C.400 W. Maple Road, Suite 350Birmingham, MI 48009United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for medical or dietetic purposes, namely, preparations for treating infectious diseases, namely, viral infections, bacterial infections, yeast infections, and for treating cancer, and for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or conditions; pharmaceutical drugs for medical or dietetic purposes, namely for treating infectious diseases, namely, viral infections, bacterial infections, yeast infections, and for treating cancer, and for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or conditions; homeopathic preparations for use in the treatment of infectious diseases, namely, viral infections, bacterial infections, yeast infections, and for treating cancer, and for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or conditions; foodstuffs for medical purposes, namely, dietetic animal foodstuffs for medical purposes; dietetic foodstuffs for medical purposes, namely dietetic foods adapted for medical use; dietetic substances in the nature of confectionery substances adapted for medical purposes; food additives based on plant extracts for medical purposes; dietary food supplements for medical or dietetic purposes; dietary fiber for use as an ingredient for medical purposes; active pharmaceutical ingredients for medical purposes, namely drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; enzymes, sugars, vitamins, vitamin preparations, minerals and mineral preparations for medical purposes; vitamin tablets; vitamin drops; gummy vitamins; effervescent vitamin tablets; fortifying medicated beverages, namely, beverages with added vitamins for medical purposes; fortifying dietetic beverages, namely, dietetic beverages with added vitamins for medical purposes; medicinal herbs and medicinal herb-based drinks; food supplements; pharmaceutical agents affecting metabolism; health food supplements for persons with special dietary requirements; pharmaceutical preparations for the prevention of diseases; nutraceuticals for use as a dietary supplement; infant formula; medical plasters; gauze materials for dressing; teeth filling material and dental wax; disinfectants; preparations for destroying noxious animals; fungicides and herbicides; sanitary preparations for medical use; dietetic substances adapted for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 28, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 17, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 26, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 26, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 17, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 16, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 16, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 16, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 30, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 30, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 30, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 10, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 10, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 22, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 20, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 20, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 4, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 4, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 4, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 7, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 17, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 17, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 30, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 29, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 28, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 24, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 23, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |